A Phase 2 Extension of Study GCS-100-CS-4003
NCT02333955
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Corporate decision
Conditions
Chronic Kidney Disease
Interventions
DRUG:
GCS-100
Sponsor
La Jolla Pharmaceutical Company